Clinical trial
Diminished Macrophage Cholesterol Efflux Mediated by HDL and Coronary Artery Disease in Young Male Anabolic Androgenic Steroid Users
NCT03450837 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diminished Macrophage Cholesterol Efflux Mediated by HDL and Coronary Artery Disease in Young Male Anabolic Androgenic Steroid Users
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2015
- Completion date
- April 1, 2017
- Enrollment
- 51 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.